Placebo for KER-012, cibotercept
KER-012-A201
Phase 2 small_molecule active
Quick answer
Placebo for KER-012, cibotercept for Pulmonary Arterial Hypertension is a Phase 2 program (small_molecule) at Keros Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Keros Therapeutics
- Indication
- Pulmonary Arterial Hypertension
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active